in this issue
New wave
Opioids, pain, and fear
Management of venous port systems in oncology: a review of current evidence
The breast cancer continuum in hormone-receptor–positive breast cancer in postmenopausal women: evolving management options focusing on aromatase inhibitors
Formaldehyde and cancer risk: a quantitative review of cohort studies through 2006
Opioid analgesics for cancer pain: symptom control for the living or comfort for the dying? A qualitative study to investigate the factors influencing the decision to accept morphine for pain caused by cancer
Psychological and behavioral mechanisms influencing the use of complementary and alternative medicine (CAM) in cancer patients
Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism
Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma
Determination of the specific activity of CDK1 and CDK2 as a novel prognostic indicator for early breast cancer
ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis
Twist expression in patients with cervical cancer is associated with poor disease outcome
A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma
An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy
A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer
Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction
Analysis of the relationship between p53 immunohistochemical expression and risk factors for lung cancer, with special emphasis on residential radon exposure
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group
Belotecan, new camptothecin analogue, is active in patients with small-cell lung cancer: results of a multicenter early phase II study
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia
Central nervous system involvement in mantle cell lymphoma
Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck
Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation
Influence of education level on cancer survival in Sweden
How common is familial cancer?
Macronutrients, fatty acids and cholesterol intake and endometrial cancer
Phase II, open-label study of PTK787/ZK222584 for the treatment of metastatic gastrointestinal stromal tumors resistant to imatinib mesylate
Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer
Markers in the epidermal growth factor receptor pathway and skin toxicity during erlotinib treatment
Trastuzumab-treated advanced breast cancer patients and brain metastases: just a little alert
Trastuzumab in pregnancy associated with poor fetal outcome
Carbon beam therapy in recurrent ovarian cancer
Chlamydia psittaci-eradicating antibiotic therapy in patients with advanced-stage ocular adnexal MALT lymphoma